the in vitro susceptibility of 230 clinical isolates , including 55 anaerobic bacteria , was tested with ceftazidime , ceftriaxone , cefotaxime , cefoperazone , moxalactam , cefamandole , cefoxitin , and ticarcillin .
C0007561
ceftriaxone
C0007554
cefotaxime